59mon MSN
Researchers at Linköping University in Sweden made an unexpected discovery while investigating genetically unique women.
Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...
Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.
The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.
Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...
4d
GlobalData on MSNGenentech eyes lupus market for Gazyva with positive Phase III data readoutRoche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...
Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...
Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Adicet Bio (ACET) announced the FDA has granted fast track designation to ADI-001 for the potential treatment of adult patients with refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results